Biohit Oyj Series B | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,452.00
4,363.00
6,051.00
8,195.00
8,979.00
9,931
Cost of Goods Sold (COGS) incl. D&A
1,908.00
2,155.00
3,142.00
4,283.00
7,900.00
8,630
Gross Income
1,544.00
2,208.00
2,909.00
3,912.00
1,079.00
1,301
SG&A Expense
7,448.00
6,957.00
6,497.00
7,189.00
2,377.00
2,884
EBIT
5,904.00
4,749.00
3,588.00
3,219.00
1,298.00
1,583
Unusual Expense
-
42.00
772.00
70.00
354.00
31
Non Operating Income/Expense
207.00
210.00
56.00
175.00
7,884.00
381
Interest Expense
224.00
22.00
198.00
107.00
24.00
28
Pretax Income
5,921.00
4,312.00
2,833.00
3,081.00
6,208.00
2,023
Income Tax
4.00
105.00
14.00
20.00
267.00
120
Equity in Affiliates
-
-
70.00
194.00
198.00
-
Consolidated Net Income
5,917.00
4,417.00
2,917.00
3,295.00
6,139.00
2,143
Net Income
5,917.00
4,417.00
2,917.00
3,295.00
6,139.00
2,143
Net Income After Extraordinaries
5,917.00
7,673.00
2,917.00
3,295.00
6,139.00
2,143
Net Income Available to Common
5,917.00
1,161.00
2,917.00
3,295.00
6,139.00
2,143
EPS (Basic)
0.43
0.08
0.20
0.22
0.42
0.14
Basic Shares Outstanding
13,727.30
13,941.30
14,276.50
14,685.10
14,764.40
14,901.90
EPS (Diluted)
0.43
0.08
0.20
0.22
0.41
0.14
Diluted Shares Outstanding
13,915.10
14,521.30
14,703.60
15,052.10
14,943.20
14,901.90
EBITDA
5,697.00
4,518.00
3,269.00
2,864.00
117.00
224
Other Operating Expense
-
-
-
58.00
-
-
Non-Operating Interest Income
-
207.00
125.00
-
-
-
About Biohit Oyj
View Profile
